other material
confidence high
sentiment negative
materiality 0.80
Enveric shareholders approve 50x increase in authorized shares and reverse split authority
Enveric Biosciences, Inc.
- Approved increase in authorized common shares from 100M to 5B (50x) at board discretion.
- Authorized reverse stock split at ratio between 1:5 and 1:15, with board to set exact ratio.
- Issuance proposal to issue shares underlying warrants for Nasdaq Rule 5635 compliance passed.
- Adjournment proposal rendered moot as quorum was achieved; all three proposals passed.